[1]
Aschieri, D., Stabile, M., Maestri, C., Rosato, L., Coccia, M.G., Novara, P., Lanati, G., Di Dio, M.T., Franco, C., Bisceglie, G., Leddi, G., Fabrizi, E., Rucci, P. and Taliani, G. 2021. Potential benefits of anticoagulant doses of low molecular weight heparin in COVID-19: An observational retrospective study. Emergency Care Journal. 17, 3 (Sep. 2021). DOI:https://doi.org/10.4081/ecj.2021.9795.